Chlamydia pneumoniae infections and development of lung cancer: systematic review

被引:0
作者
Nadeesha Madushani Premachandra
J. A. A. Sampath Jayaweera
机构
[1] Rajarata University of Sri Lanka,Department of Microbiology, Faculty of Medicine and Allied Sciences
来源
Infectious Agents and Cancer | / 17卷
关键词
Lung cancer; Risk factor; Serology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 140 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2016)Classification and pathology of lung cancer Surg Oncol Clin N Am 25 447-468
[3]  
Soerjomataram I(2015)Transforming Chlamydia pneumoniae in human mesothelial cells Int Microbiol 17 2568-1630
[4]  
Zheng M(2020)Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China BMC Cancer 20 903-5797
[5]  
Rizzo A(2010)Chlamydia pneumoniae infection and risk for lung cancer Cancer Epidemiol Biomark Prev 19 879-1266
[6]  
Carratelli CR(2004)Chlamydia pneumoniae infection and risk of lung cancer Cancer Epidemiol Biomark Prev 13 1624-34
[7]  
De Filippis A(2019)Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China Cancer Manag Res 28 5785-129
[8]  
Nazario B(2000)Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer Cancer Epidemiol Biomark Prev 9 1263-726
[9]  
Tufano MA(1997)Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer Int J Cancer 74 31-580
[10]  
Buommino E(2010)Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China Thorac Cancer 1 126-420